@inproceedings{inproceedings, title  = {{Integrated analysis of abrocitinib for the treatment of adolescents with moderate-to-severe atopic dermatitis from the phase 3 clinical trial program}},

 url = {{}},

 year = {{2022}},

 month = {{1}},

 author = {{Paller A and Eichenfield LF and Cork MJ}},

 volume = {{87}},

 journal = {{JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY}},

 issue = {{3}},

 pages = {{AB72-AB72}},

 note = {{Accessed on 2025/10/26}}}